Switching from branded alendronate or risedronate to generic alendronate: effect on persistence with bisphosphonate therapy in Germany

Ziller V Schüssel K Czeche S Franzmann A Klöckner D Quinzler R Schulz M Möhrke W Hadji P

36^th European Symposium on Calcified Tissues, 23. - 27.05.2009, Vienna, Austria.

ECTS 2009, Wien; Poster: Switching from branded alendronate or risedronate to generic alendronate: effect on persistence with bisphosphonate therapy in Germany

Bone 2009; 44 (Suppl. 2): S449 (Abstract P511)

Interessenskonflikte: W.Moehrke, Procter and Gamble Pharmaceuticals, Employee; M.Schulz, Procter and Gamble Pharmaceuticals, Grant; P.Hadji, Procter and Gamble Pharmaceuticals, Consultant.